Interferon Therapy in Hodgkin's Disease

Publisher Website
Google Scholar
Abstract
The treatment of a case of Hodgkin's disease (lymphocyte predominance, stage IVB) with exogenous i.m. interferon therapy is described. B symptoms disappeared, diseased nodes and pulmonary infiltrations decreased in size, and laboratory values normalized. Clinical improvement was associated with increased mitogenic responsiveness of the patient's lymphocytes towards various stimuli in vitro. After almost half a year's treatment tumour progression and a decreased mitogenic response were again observed. Interferon treatment was then abandoned and combined cytostatic courses were instituted. Partial remission was achieved after 6 months of cytostatic therapy, i.e. 1 year after the start of treatment.

This publication has 9 references indexed in Scilit: